Crinetics Pharmaceuticals... (CRNX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
36.59
0.97 (2.72%)
At close: Jan 15, 2025, 12:42 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
PE Ratio | -9.63 | -5.95 | -10.23 | -5.9 | -12.24 | -13.43 | -37.15 | -56.51 |
PS Ratio | 514.87 | 200.82 | 1.01K | 6.05K | 508.42 | 149.97 | 166.33 | 577.51 |
PB Ratio | 3.83 | -2.17 | -3.97 | -2.56 | -6.47 | -8.39 | -22.64 | -54.83 |
P/FCF Ratio | -12.08 | -8.14 | -12.27 | -6.91 | -12.94 | -17.75 | -34.77 | -60.12 |
P/OCF Ratio | -12.42 | -8.26 | -12.33 | -6.93 | -13.08 | -18.71 | -35.88 | -62.21 |
OCF/S Ratio | -41.44 | -24.32 | -82.18 | -873.62 | -38.88 | -8.01 | -4.64 | -9.28 |
Debt / Equity Ratio | 0.10 | -0.00 | -0.01 | -0.02 | -0.05 | n/a | n/a | -0.03 |
Quick Ratio | 13.07 | 12.45 | 21.05 | 17.10 | 14.95 | 21.03 | 16.75 | 13.78 |
Current Ratio | 13.07 | 12.45 | 21.55 | 16.92 | 14.79 | 21.03 | 16.91 | 13.89 |
Asset Turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.13 | 0.05 |
Interest Coverage | n/a | -38.89 | n/a | n/a | n/a | n/a | -1.14K | -549.45 |
Return on Equity (ROE) | -0.4 | 0.36 | 0.39 | 0.43 | 0.53 | 0.63 | 0.61 | 0.97 |
Return on Assets (ROA) | -0.34 | -0.45 | -0.3 | -0.4 | -0.38 | -0.16 | -0.59 | -0.48 |
Return on Capital (ROIC) | -0.38 | -0.52 | -0.32 | -0.43 | -0.44 | -0.18 | -0.62 | -0.52 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | 70.68% | -17.07% | -80.18K% | 6.71% | -908.2% | -351.49% | -765.87% |
Net Profit Margin | -5.35K% | -3.38K% | -9.90K% | -102.63K% | -4.15K% | -1.12K% | -447.78% | -1.02K% |
Pretax Profit Margin | -5.35K% | -3.46K% | -9.99K% | -103.96K% | -4.23K% | -1.12K% | -447.78% | -1.02K% |
Operating Profit Margin | -5.55K% | -3.54K% | -9.99K% | -105.57K% | -4.51K% | -1.18K% | -446.31% | -1.03K% |
FCF Margin | -4.26K% | -2.47K% | -8.26K% | -87.62K% | -3.93K% | -845.06% | -478.39% | -960.61% |
EBITDA Margin | -5.52K% | -3.52K% | -9.91K% | -102.23K% | -4.13K% | -1.16K% | -440.05% | -1.01K% |